TCI Wealth Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-144
Closed -$1K 1622
2018
Q4
$1K Buy
144
+68
+89% +$415 ﹤0.01% 1402
2018
Q3
$0 Buy
+76
New +$380 ﹤0.01% 1663

Other funds holding PETX

TCI Wealth Advisors's PETX Position: Q1 2019 in Review

TCI Wealth Advisors sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2019, closing a stake of 144 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in PETX in Q3 2018 and held it in 2 quarters. The position peaked at $1K in Q4 2018. 104 funds tracked by Wall St. Rank hold PETX as of Q1 2019.

  • TCI Wealth Advisors reported no remaining Aratana Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • TCI Wealth Advisors sold 144 Aratana Therapeutics, Inc. shares in Q1 2019, an estimated $1K.
  • TCI Wealth Advisors first reported a position in Aratana Therapeutics, Inc. in Q3 2018 and held it in 2 quarters.
  • TCI Wealth Advisors's Aratana Therapeutics, Inc. position peaked at $1K in Q4 2018.
  • 104 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2019.

Based on TCI Wealth Advisors's 13F filing for Q1 2019, filed 11 Apr 2019.